As many continue to monitor the biotechs, and deservedly so as the XBI is now looking for a TWELVE week winning streak (although last week was a spinning top, and this week thus far is again), the XLV is making a name for itself. The ETF is attempting to carve out its own 10 week winning streak, higher by 1.2% with 2 sessions left. The almost complete recovery by JNJ, which we will take about in this note, the top component in the fund is helping. UNH, the second largest holding, has rallied 80 handles from top to bottom since the beginning of October. That stock is acting very well POST breakout from a 268.79 cup base pattern taken out on 11/15 jumping more than 5% in double average daily volume. And the third largest name in the XLV is MRK, and for the moment is being held up by the very round 90 number. The way this group is behaving, expect that to be temporary.